Hongmei Tan

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparison With Rituximab.

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparison With Rituximab.

Journal: Annals of clinical and translational neurology

Published: November 27, 2025

Siponimod for relapsing-remitting multiple sclerosis: a single-center, real-world cohort study in China.

Siponimod for relapsing-remitting multiple sclerosis: a single-center, real-world cohort study in China.

Journal: BMC neurology

Published: October 12, 2025

Outcomes and predictors of relapse and severe pneumonia in Chinese patients with AQP4-IgG-positive neuromyelitis optica spectrum disorder receiving inebilizumab: a prospective cohort study.

Outcomes and predictors of relapse and severe pneumonia in Chinese patients with AQP4-IgG-positive neuromyelitis optica spectrum disorder receiving inebilizumab: a prospective cohort study.

Journal: Frontiers in immunology

Published: October 04, 2025

CXCL9 associates with experimental neuromyelitis optica spectrum disorder following adoptive transfer of Tfh and Th17 cells.

CXCL9 associates with experimental neuromyelitis optica spectrum disorder following adoptive transfer of Tfh and Th17 cells.

Journal: Frontiers in immunology

Published: September 12, 2025

Dysregulated Tfh/B cells and their interactions in neuromyelitis optica spectrum disorder.

Dysregulated Tfh/B cells and their interactions in neuromyelitis optica spectrum disorder.

Journal: Frontiers in immunology

Published: September 12, 2025

Retinal nerve fiber layer thinning in multiple sclerosis: clinical implications, cognitive associations, and effects of disease-modifying therapies.

Retinal nerve fiber layer thinning in multiple sclerosis: clinical implications, cognitive associations, and effects of disease-modifying therapies.

Journal: Journal of neurology

Published: August 31, 2025

Glial fibrillary acidic protein autoimmunity in reversible splenial lesion syndrome: diagnostic and therapeutic implications.

Glial fibrillary acidic protein autoimmunity in reversible splenial lesion syndrome: diagnostic and therapeutic implications.

Journal: Frontiers in neurology

Published: June 19, 2025

Eculizumab for the acute attack of neuromyelitis optica spectrum disorder.

Eculizumab for the acute attack of neuromyelitis optica spectrum disorder.

Journal: Frontiers in immunology

Published: June 11, 2025

Fluctuations in serum aquaporin-4 antibody titers: the clinical significance in neuromyelitis optica spectrum disorder.

Fluctuations in serum aquaporin-4 antibody titers: the clinical significance in neuromyelitis optica spectrum disorder.

Journal: Journal of neurology

Published: February 26, 2025

KFLC-index distinguishes multiple sclerosis from anti-myelin oligodendrocyte glycoprotein and aquaporin 4 diseases in a Chinese cohort.

KFLC-index distinguishes multiple sclerosis from anti-myelin oligodendrocyte glycoprotein and aquaporin 4 diseases in a Chinese cohort.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: January 31, 2025

Fewer relapses and worse outcomes of patients with late-onset myelin oligodendrocyte glycoprotein antibody-associated disease.

Fewer relapses and worse outcomes of patients with late-onset myelin oligodendrocyte glycoprotein antibody-associated disease.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: July 10, 2024

Multiple sclerosis associated with adalimumab use in ankylosing spondylitis.

Multiple sclerosis associated with adalimumab use in ankylosing spondylitis.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: January 03, 2024

Showing 1-12 of 25

Last Updated: 09/26/2026